Check-Cap (CHEK) Competitors $0.80 +0.04 (+5.04%) (As of 02:30 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends CHEK vs. MHUA, LFWD, IINN, NEPH, PYPD, AMIX, MBOT, VVOS, SSKN, and LYRAShould you be buying Check-Cap stock or one of its competitors? The main competitors of Check-Cap include Meihua International Medical Technologies (MHUA), ReWalk Robotics (LFWD), Inspira Technologies Oxy B.H.N. (IINN), Nephros (NEPH), PolyPid (PYPD), Autonomix Medical (AMIX), Microbot Medical (MBOT), Vivos Therapeutics (VVOS), STRATA Skin Sciences (SSKN), and Lyra Therapeutics (LYRA). These companies are all part of the "medical equipment" industry. Check-Cap vs. Meihua International Medical Technologies ReWalk Robotics Inspira Technologies Oxy B.H.N. Nephros PolyPid Autonomix Medical Microbot Medical Vivos Therapeutics STRATA Skin Sciences Lyra Therapeutics Check-Cap (NASDAQ:CHEK) and Meihua International Medical Technologies (NASDAQ:MHUA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, earnings, institutional ownership, profitability, community ranking, valuation and risk. Is CHEK or MHUA more profitable? Company Net Margins Return on Equity Return on Assets Check-CapN/A N/A N/A Meihua International Medical Technologies N/A N/A N/A Does the MarketBeat Community prefer CHEK or MHUA? Check-Cap received 370 more outperform votes than Meihua International Medical Technologies when rated by MarketBeat users. CompanyUnderperformOutperformCheck-CapOutperform Votes37063.14% Underperform Votes21636.86% Meihua International Medical TechnologiesN/AN/A Does the media prefer CHEK or MHUA? In the previous week, Check-Cap had 1 more articles in the media than Meihua International Medical Technologies. MarketBeat recorded 1 mentions for Check-Cap and 0 mentions for Meihua International Medical Technologies. Check-Cap's average media sentiment score of 0.00 equaled Meihua International Medical Technologies'average media sentiment score. Company Overall Sentiment Check-Cap Neutral Meihua International Medical Technologies Neutral Which has stronger earnings and valuation, CHEK or MHUA? Meihua International Medical Technologies has higher revenue and earnings than Check-Cap. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCheck-CapN/AN/A-$17.57M-$3.00-0.26Meihua International Medical Technologies$97.10M0.18$11.62MN/AN/A Do insiders & institutionals hold more shares of CHEK or MHUA? 1.1% of Check-Cap shares are owned by institutional investors. Comparatively, 1.2% of Meihua International Medical Technologies shares are owned by institutional investors. 0.5% of Check-Cap shares are owned by insiders. Comparatively, 66.6% of Meihua International Medical Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more risk & volatility, CHEK or MHUA? Check-Cap has a beta of 0.39, meaning that its share price is 61% less volatile than the S&P 500. Comparatively, Meihua International Medical Technologies has a beta of 0.54, meaning that its share price is 46% less volatile than the S&P 500. SummaryMeihua International Medical Technologies beats Check-Cap on 5 of the 7 factors compared between the two stocks. Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Get Check-Cap News Delivered to You Automatically Sign up to receive the latest news and ratings for CHEK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CHEK vs. The Competition Export to ExcelMetricCheck-CapX IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.62M$347.41M$5.09B$8.79BDividend YieldN/AN/A5.04%4.07%P/E Ratio-0.26N/A93.0914.02Price / SalesN/A10.481,220.6787.41Price / CashN/AN/A39.4936.27Price / Book0.202.006.936.33Net Income-$17.57M-$75.64M$118.83M$225.71M7 Day Performance-1.40%11.34%-1.74%-0.58%1 Month Performance-45.90%18.15%-3.60%1.49%1 Year Performance-76.90%72.45%31.91%27.23% Check-Cap Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CHEKCheck-Cap0.5192 of 5 stars$0.80+5.0%N/A-76.9%$4.68MN/A-0.2780Upcoming EarningsNews CoverageGap UpMHUAMeihua International Medical Technologies0.3433 of 5 stars$0.69+6.9%N/A-66.4%$17.41M$97.10M0.00620Gap UpLFWDReWalk Robotics3.5648 of 5 stars$1.94+4.9%$13.00+570.1%N/A$17.09M$13.85M-0.7460IINNInspira Technologies Oxy B.H.N.0.3151 of 5 stars$1.34+1.5%N/A+11.3%$16.91MN/A0.0020News CoverageGap UpNEPHNephros2.2003 of 5 stars$1.56-1.9%$5.00+220.5%-24.3%$16.44M$14.24M0.0030Gap DownPYPDPolyPid2.877 of 5 stars$3.37-3.4%$12.00+256.1%-14.3%$16.18MN/A0.0080Positive NewsGap DownAMIXAutonomix Medical2.2559 of 5 stars$13.69+2.5%$28.00+104.5%N/A$15.74MN/A0.001MBOTMicrobot Medical1.7391 of 5 stars$0.91-1.4%$7.00+671.6%-32.8%$15.36MN/A-1.1520Negative NewsGap UpVVOSVivos Therapeutics2.1857 of 5 stars$2.94+1.7%$6.30+114.3%-34.2%$14.23M$13.80M-0.52160Analyst ForecastSSKNSTRATA Skin Sciences0.5693 of 5 stars$3.10+0.3%N/A-40.7%$12.93M$33.36M0.00120LYRALyra Therapeutics3.3367 of 5 stars$0.19+4.0%$4.50+2,329.8%-94.1%$12.12M$1.56M0.0050Analyst RevisionNews Coverage Related Companies and Tools Related Companies MHUA Alternatives LFWD Alternatives IINN Alternatives NEPH Alternatives PYPD Alternatives AMIX Alternatives MBOT Alternatives VVOS Alternatives SSKN Alternatives LYRA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CHEK) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Check-Cap Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Check-Cap With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
